Extracorporeal hepatic resection for advanced liver cancer

Keishi Sugimachi, Ken Shirabe, Akinobu Taketomi, Yuji Soejima, Hideaki Uchiyama, Mizuki Ninomiya, Hiroto Kayashima, Dai Kitagawa, Hidefumi Higashi, Yoshihiko Maehara

Research output: Contribution to journalArticlepeer-review

Abstract

Hepatic resection is the most curative treatment for the patient with hepatocellular carcinoma (HCC) which occurs in the non-cirrhotic liver. It is not common, but extracorporeal hepatic resection (EHR) is sometimes considered as the treatment of otherwise unresectable tumors due to the location, size, and vascular invasion of the tumor. In the EHR, the liver is completely removed and perfused with the preservation solution. Bloodless transection of hepatic parenchyma is done, and reimplanted in the patient. Preoperative assessment of the vascular anatomy and liver volume, advanced surgical technique of hepatic resection and transplantation, and experienced postoperative care are essential to the accomplishment of EHR. In this issue, we give an outline of the indication, procedures, and the problems of EHR.

Original languageEnglish
Pages (from-to)399-401
Number of pages3
JournalJapanese Journal of Cancer and Chemotherapy
Volume37
Issue number3
Publication statusPublished - Mar 6 2010

All Science Journal Classification (ASJC) codes

  • Oncology
  • Cancer Research

Fingerprint Dive into the research topics of 'Extracorporeal hepatic resection for advanced liver cancer'. Together they form a unique fingerprint.

Cite this